Lyell Immunopharma, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 06/08/2026 | Mar 2026Filed 06/05/2026 | Sep 2025Filed 12/11/2025 | Jun 2025Filed 06/08/2026 | Mar 2025Filed 06/05/2026 | Sep 2024Filed 12/11/2025 | Jun 2024Filed 12/08/2025 | Mar 2024Filed 13/05/2025 |
|---|---|---|---|---|---|---|---|---|
| $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| −$45 | −$24 | −$39 | −$43 | −$52 | −$45 | −$46 | −$61 | |
| −$1.92 | −$1.10 | −$2.13 | −$2.89 | −$3.54 | −$3.48 | −$3.59 | −$0.24 | |
| 23 | 22 | 18 | 15 | — | — | — | 254 |
Trend